Clik here to view.
Fukushima SiC Applied Engineering Inc. Raises USD 30 Million (JPY 3.1...
FUKUSHIMA, Japan Fukushima SiC Applied Engineering Inc., the Naraha, Fukushima headquartered Silicon carbide technology company developing the next generation of BNCT* radiotherapy solutions, has...
View ArticleClik here to view.
Clik here to view.
Zion Pharma Announces Initiation of Phase 1 Study
HONG KONG & SHANGHAI & SUZHOU, China Zion Pharma Limited, an emerging Chinese biotechnology company focused on the development of brain-penetrable compounds, today announced the initiation...
View ArticleClik here to view.
Takeda Divests Select Non-Core Assets in Europe to Cheplapharm for...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select non-core prescription...
View ArticleClik here to view.
福岛SiC应用技研株式会社在C轮融资中筹得3,000万美元（31亿日元）
日本福岛 (美国商业资讯)–总部位于福岛县楢叶町、正在开发下一代BNCT*放疗解决方案的碳化硅技术公司福岛SiC应用技研株式会社(Fukushima SiC Applied Engineering Inc.)已在C轮融资中筹得3,000万美元（31亿日元），投资者包括C:iz Investment LLP、Japan Post Investment Corporation、Astellas...
View ArticleClik here to view.
CANbridge Pharmaceuticals Enters into Second Rare Disease Gene Therapy...
BEIJING & CAMBRIDGE, Mass CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions, announced that it has...
View ArticleClik here to view.
Hong Kong Secures Multiple First-Ever MICE Events Amidst COVID-19 Challenges
HONG KONG The Hong Kong Tourism Board (HKTB) announced that Hong Kong has been recently chosen as the host city for 4 international MICE events, including the city’s first-ever events of high...
View ArticleClik here to view.
无惧疫情阴霾 香港赢得多个大型国际会展活动选址为举办城市
香港 (美国商业资讯)– 香港旅游发展局（旅发局）公佈，尽管疫情阴霾未散，多个会展活动纷纷选址香港作为目的地，包括四个国际性会展活动，其中更有具重要战略意义的活动首度在香港举行，另有两个活动继续以香港为主办城市。各会展商务活动预计将为香港带来约1万名高消费会展访客，有利于重振本地多个行业，为香港的经济注入新活力。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Apros Therapeutics Announces IND Clearance from U.S. FDA to Initiate the...
SAN DIEGO Apros Therapeutics, Inc., a drug discovery and development company focused on tissue-targeted Toll-Like Receptor 7 (TLR7) agonists for the treatment of cancer and infectious diseases,...
View ArticleClik here to view.
KILL Desk Lamps With Seoul Semiconductor’s SunLike Series Natural Spectrum...
Seoul Semiconductor requests that their press release NewsItemId: 20200910006083 issued September 11, 2020 “Desk Lamps With Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Sold at Costco,...
View ArticleClik here to view.
TransEnterix Announces Establishment of Japanese Training Center for Senhance...
RESEARCH TRIANGLE PARK, N.C. TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive...
View ArticleClik here to view.
HiFiBiO Therapeutics Announces a Global Strategic Partnership With ABL Bio...
CAMBRIDGE, Mass. & PARIS & SHANGHAI & HONG KONG HiFiBiO Therapeutics, a clinical-stage multinational biotherapeutics company focused on the development of novel antibodies in...
View ArticleClik here to view.
Daiichi Sankyo Initiates Phase 2 Study of Patritumab Deruxtecan in Patients...
TOKYO & BASKING RIDGE, N.J. & MUNICH Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that the first patient has been dosed in a phase 2 study evaluating...
View ArticleClik here to view.
Guided Therapeutics Ships LuViva Devices and Disposables for Chinese FDA...
PEACHTREE CORNERS, Ga. Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced that it had shipped four...
View ArticleClik here to view.
Genomic Leaders Collaborate to Create Australia’s First National COVID-19...
MELBOURNE, Australia Illumina (NASDAQ: ILMN) announced today that the Australian public health laboratories will aim to sequence the virus genomes of all positive COVID-19 tests in Australia and...
View ArticleClik here to view.
EpimAb Biotherapeutics Announces FDA Clearance of its IND Application for...
SHANGHAI EpimAb Biotherapeutics, a clinical stage biotech company specializing in bispecific antibodies, today announced that it has received “STUDY MAY PROCEED” letter from the U.S. Food and Drug...
View ArticleClik here to view.
Mutsuki Takano Was Appointed as CFO at Heartseed
TOKYO Heartseed Inc. (hereinafter Heartseed), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocyte spheroids for the treatment of heart failure (HF), today announced that...
View ArticleClik here to view.
Forma Therapeutics Appoints Two New Vice Presidents to Lead Key...
WATERTOWN, Mass. Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the appointments of...
View ArticleClik here to view.
Takeda Opens New R&D Cell Therapy Manufacturing Facility to Support Expansion...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the expansion of its cell therapy manufacturing capabilities with the opening of a new 24,000...
View ArticleClik here to view.
Santen and Aerie Conclude Exclusive License Agreement for Rhopressa® and...
OSAKA, Japan & DURHAM, N.C. Santen Pharmaceutical Co., Ltd. (“Santen”) and Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”) announced that Santen and Aerie have entered into an exclusive...
View Article